The diabetes segment in the global prefilled syringes market is estimated to account for a majority revenue share of 34.2% in 2017. The first five-year cumulative revenue (2017–2021) of this segment is projected to be US$ 7,825.0 Mn, compared to a moderately higher cumulative revenue total of US$ 12,524.1 Mn for the latter five years of the forecast period (2022–2026)
Read More at https://marketresearch.biz/report/prefilled-syringes-market/
